SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.

Autor: Papadopoulou A; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Karavalakis G; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Papadopoulou E; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Xochelli A; Department of Immunology, National Peripheral Histocompatibility Center, Hippokration General Hospital, Thessaloniki, Greece., Bousiou Z; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Vogiatzoglou A; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Papayanni PG; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Georgakopoulou A; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Giannaki M; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Stavridou F; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Vallianou I; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Kammenou M; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Varsamoudi E; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Papadimitriou V; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Giannaki C; 'A' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Sileli M; 'B' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Stergiouda Z; Department of Anesthesiology, George Papanikolaou Hospital, Thessaloniki, Greece., Stefanou G; ECONCARE LP, Athens, Greece., Kourlaba G; Department of Nursing, University of Peloponnese, Tripolis, Greece., Gounelas G; ECONCARE LP, Athens, Greece., Triantafyllidou M; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Siotou E; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Karaglani A; Euromedica Arogi Rehabilitation Center, Thessaloniki, Greece., Zotou E; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Chatzika G; Department of Immunology, National Peripheral Histocompatibility Center, Hippokration General Hospital, Thessaloniki, Greece., Boukla A; Department of Immunology, National Peripheral Histocompatibility Center, Hippokration General Hospital, Thessaloniki, Greece., Papalexandri A; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Koutra MG; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Apostolou D; Department of Respiratory Failure, George Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Pitsiou G; Department of Respiratory Failure, George Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Morfesis P; 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Doumas M; 2nd Propedeutic Department of Internal Medicine, Hippokrateio Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Karampatakis T; Department of Microbiology, George Papanikolaou Hospital, Thessaloniki, Greece., Kapravelos N; 'B' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Bitzani M; 'A' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Theodorakopoulou M; National and Kapodistrian University of Athens, Evaggelismos General Hospital, Athens, Greece., Serasli E; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Georgolopoulos G; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Sakellari I; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Fylaktou A; Department of Immunology, National Peripheral Histocompatibility Center, Hippokration General Hospital, Thessaloniki, Greece., Tryfon S; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Anagnostopoulos A; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Yannaki E; Hematopoietic Cell Transplantation Unit, Department of Hematology Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece. eyannaki@u.washington.edu.; Department of Medicine, University of Washington, Seattle, WA, USA. eyannaki@u.washington.edu.

Publikováno v: Nature medicine [Nat Med] 2023 Aug; Vol. 29 (8), pp. 2019-2029. Date of Electronic Publication: 2023 Jul 17.

Gender and innovation in STE(A)M education

Autor: Jiménez Iglesias, M, Müller, J, Ruiz-Mallén, I, Kim, E, Cripps, E, Heras, M, Filipecki Martins, S, van Laar, M, Tramonti, M, Valenzuela-Zapata, A, Gras-Velázquez, A, Akue Da Silva, A, Alexopoulos, A, Baldursson, R, Bes, M, Benameur, Z, Bogner, FX, Cala, V, Ceuleers, E, Daras, D, Dochshanov, A, Giampaoli, D, Kırmacı, H, Kolenberg, Katrien, Martev, I, Ronsijn, S, Siotou, E, Tortosa, M, Vizzini, C

Gender aspects continue to play an important role in science education, conditioning study choices or shaping beliefs about one's own capacities and those of others. Performing arts based initiatives are on the forefront of innovative science educati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1131::2a6695d792e417e36dcb60243f2c3512
https://lirias.kuleuven.be/handle/123456789/637577

Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.

Autor: Papayanni PG; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Chasiotis D; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Koukoulias K; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Georgakopoulou A; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Iatrou A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Gavriilaki E; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Giannaki C; A' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Bitzani M; A' Intensive Care Unit, George Papanikolaou Hospital, Thessaloniki, Greece., Geka E; Intensive Care Unit, AHEPA University Hospital, Thessaloniki, Greece., Tasioudis P; Intensive Care Unit, AHEPA University Hospital, Thessaloniki, Greece., Chloros D; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Fylaktou A; National Peripheral Histocompatibility Center, Immunology Department, Hippokration General Hospital, Thessaloniki, Greece., Kioumis I; Respiratory Failure Department, George Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Triantafyllidou M; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Dimou-Besikli S; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Karavalakis G; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Boutou AK; Department of Respiratory Medicine, George Papanikolaou Hospital, Thessaloniki, Greece., Siotou E; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Anagnostopoulos A; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Papadopoulou A; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece., Yannaki E; Hematology Department-Hematopoietic Cell Transplantation Unit, Gene and Cell Therapy Center, George Papanikolaou Hospital, Thessaloniki, Greece.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Dec 06; Vol. 73 (11), pp. 2073-2082.

In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice

Autor: Samalidou, M. Bougiouklis, D. Vyzantiadis, T.-A. Meletiadis, J. Monokrousos, N. Siotou, E. Sivropoulou, A. Anagnostopoulos, A. Sotiropoulos, D.

Liposomal amphotericin B, voriconazole, and caspofungin are currently used for systemic and severe fungal infections. Patients with malignant diseases are treated with granulocyte-colony stimulating factor (G-CSF) for the recovery of granulocytes aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::221aeee9a764a502ba760f783d38c8af
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088951

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.